Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DiagnaMed
Toronto, Ontario, Canada
- Ownership
- Private
- Development stage
- Other
01
Overview
DiagnaMed’s BRAIN AGE® and CERVAI™ platforms are validated for noninvasive brain age/cognitive decline assessment via EEG and AI, supporting early intervention and tracking; hydrogen-based therapies are in research/preclinical stage targeting neurological health[1][2][5].
- Therapeutic areas
- Infectious DiseasesNeurologyPsychiatry
- Modalities
- Device (EEG-based diagnostic platform)Small molecule (molecular hydrogen therapy)
- Industry
- Biotech
02
Partnerships
Drexel University (research and development for CERVAI™[5])TerraVent Environmental Inc. (hydrogen extraction technology)[4]Quebec Innovative Materials Corp (hydrogen exploration)[4]Texas Tech University (hydrogen stimulation technology)[4]
Beyond the preview
Go deeper on DiagnaMed.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on DiagnaMed.